A new threat to at-risk individuals, and a new challenge for care providers
KEVIN J. ARMINGTON, M.D.
Adefovir effective in patients resistant to ZDV and 3TC ... Human papilloma virus and anal cancer ... Clinical trials vs. the clinic ... Thalidomide for aphthous ulcers ... Update: Treatment of CMV retinitis ... Update: Stopping PCP prophylaxis ... Lodenosine Study Suspended
OPTIMAL MEDICAL MANAGEMENT
New approaches to the clinical care of patients with wasting syndrome and lipodystrophy
MARC K. HELLERSTEIN, M.D., PH.D.
This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline.